Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropicamide 0.5% vs 1% in Diabetic Patients
NCT04932213Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jul 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of tropicamide, sponsored by Semnan University of Medical Sciences. Primary endpoint: Intraocular Pressure at 30 minutes. Started Jul 2021; status: completed.
02
Drugs
tropicamide
Beyond the preview
Go deeper on NCT04932213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04932213.